Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease
- DOI
- 10.1002/trc2.70313
- Published
- 2026-07
- Container
- Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/trc2.70313,
title = {Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease},
author = {Gihwan Byeon and Jung‐Won Lee and Suhyung Kim and Yoo Hyun Um and Sheng‐Min Wang and Seunggyun Ha and Sonya Youngju Park and Ilah Shin and Jinhee Jang and Chang Uk Lee and Hyun Kook Lim and Dong Woo Kang},
year = {2026},
journal = {Alzheimer's \& Dementia: Translational Research \& Clinical Interventions},
doi = {10.1002/trc2.70313},
url = {https://doi.org/10.1002/trc2.70313}
}RIS
TY - JOUR TI - Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease AU - Gihwan Byeon AU - Jung‐Won Lee AU - Suhyung Kim AU - Yoo Hyun Um AU - Sheng‐Min Wang AU - Seunggyun Ha AU - Sonya Youngju Park AU - Ilah Shin AU - Jinhee Jang AU - Chang Uk Lee AU - Hyun Kook Lim AU - Dong Woo Kang PY - 2026 JO - Alzheimer's & Dementia: Translational Research & Clinical Interventions DO - 10.1002/trc2.70313 UR - https://doi.org/10.1002/trc2.70313 ER -
APA
Byeon, G., Lee, J., Kim, S., Um, Y. H., Wang, S., Ha, S., Park, S. Y., Shin, I., Jang, J., Lee, C. U., Lim, H. K., & Kang, D. W. (2026). Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70313
Source records
- crossref · retrieved 2026-09-25T02:47:20.531Z